Literature DB >> 9042651

On the causes of lung hyperinflation during bronchoconstriction.

R Pellegrino1, V Brusasco.   

Abstract

Airway obstruction in asthma and chronic obstructive pulmonary disease (COPD) is often associated with lung hyperinflation. In this review, we examine the mechanisms that may cause functional residual capacity (FRC), residual volume (RV) and total lung capacity (TLC) to increase during acute and chronic airway obstruction. Normally, FRC at rest is determined by the static characteristics of the lung and chest wall. When airways narrow, FRC may be also be determined by dynamic factors. There are data suggesting that expiratory flow limitation during tidal breathing represents the starting trigger for FRC to increase, in order to allow breathing at higher flows. Indeed, the increase in FRC during induced bronchoconstriction in asthma is closely associated with the occurrence of flow limitation, i.e. the achievement of maximum flow during tidal breathing. Conversely, the decrease in FRC following bronchodilatation in COPD is closely associated with flow limitation disappearing or occurring at lower lung volumes. In normal young people, RV is determined by the static characteristics of the chest wall. During bronchoconstriction RV may also be determined by dynamic factors; therefore, changes in flow or airway calibre at low lung volumes may modulate RV during bronchoconstriction. During acutely induced bronchoconstriction, RV achieved with an expiration from TLC is less than with an expiration from tidal breathing, and this effect appears to be linked to the bronchodilator effect of the deep inhalation. The reasons for the increase in TLC during airway narrowing are not clear, but the duration of the bronchoconstriction by itself may play a role.

Entities:  

Mesh:

Year:  1997        PMID: 9042651     DOI: 10.1183/09031936.97.10020468

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  9 in total

1.  Exhaled metallic elements and serum pneumoproteins in asymptomatic smokers and patients with COPD or asthma.

Authors:  Antonio Mutti; Massimo Corradi; Matteo Goldoni; Maria Vittoria Vettori; Alfred Bernard; Pietro Apostoli
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

2.  Effects of cannabis on pulmonary structure, function and symptoms.

Authors:  Sarah Aldington; Mathew Williams; Mike Nowitz; Mark Weatherall; Alison Pritchard; Amanda McNaughton; Geoffrey Robinson; Richard Beasley
Journal:  Thorax       Date:  2007-07-31       Impact factor: 9.139

3.  Regional pulmonary perfusion, inflation, and ventilation defects in bronchoconstricted patients with asthma.

Authors:  R Scott Harris; Tilo Winkler; Nora Tgavalekos; Guido Musch; Marcos F Vidal Melo; Tobias Schroeder; Yuchiao Chang; José G Venegas
Journal:  Am J Respir Crit Care Med       Date:  2006-05-11       Impact factor: 21.405

4.  Hypoxic Pulmonary Vasoconstriction Does Not Explain All Regional Perfusion Redistribution in Asthma.

Authors:  Vanessa J Kelly; Kathryn A Hibbert; Puja Kohli; Mamary Kone; Elliot E Greenblatt; Jose G Venegas; Tilo Winkler; R Scott Harris
Journal:  Am J Respir Crit Care Med       Date:  2017-10-01       Impact factor: 21.405

Review 5.  An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease.

Authors:  Mark A Giembycz
Journal:  Br J Clin Pharmacol       Date:  2006-08       Impact factor: 4.335

6.  Longitudinal lung volume changes in patients with chronic obstructive pulmonary disease.

Authors:  Jae Seung Lee; Seon Ok Kim; Joon Beom Seo; Ji-Hyun Lee; Eun Kyung Kim; Tae-Hyung Kim; Woo Jin Kim; Jin Hwa Lee; Sang-Min Lee; Sangyeub Lee; Seong Yong Lim; Tae Rim Shin; Ho Il Yoon; Sei Won Lee; Jin Won Huh; Yeon-Mok Oh; Sang-Do Lee
Journal:  Lung       Date:  2013-05-29       Impact factor: 2.584

7.  Increased circulating β2-adrenergic receptor autoantibodies are associated with smoking-related emphysema.

Authors:  Jia-Yi Hu; Bei-Bei Liu; Yi-Peng Du; Yuan Zhang; Yi-Wei Zhang; You-Yi Zhang; Ming Xu; Bei He
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

8.  Serum periostin reflects dynamic hyperinflation in patients with asthma.

Authors:  Takamitsu Asano; Hiroyuki Ohbayashi; Mitsue Ariga; Osamu Furuta; Sahori Kudo; Junya Ono; Kenji Izuhara
Journal:  ERJ Open Res       Date:  2020-07-20

9.  Elevation in lung volume and preventing catastrophic airway closure in asthmatics during bronchoconstriction.

Authors:  Juan S Osorio-Valencia; Chanikarn Wongviriyawong; Tilo Winkler; Vanessa J Kelly; Robert S Harris; Jose G Venegas
Journal:  PLoS One       Date:  2018-12-19       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.